drugset / Trial / NCT01221636
Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept
RandomizedParallel-groupOpen-label
Summary
The purpose of this study is to determine whether the blood levels of abatacept drug product manufactured using High Metals and using Low Metals are comparable in healthy subjects.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | 750 mg | Intravenous |